LSD1 up-regulates LEF1 (lymphoid enhancer binding factor 1) through β-catenin to promote the epithelial–mesenchymal transition of bladder cancer and tumor progression.73 This evidence concerns the gene LEF1 and urinary bladder carcinoma.